Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cruciani

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 3, 2021
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapiesFioravante Capone, Matteo Lucchini, Elisabetta Ferraro, et al.
Peerj|September 22, 2016
ECG is an inefficient screening-tool for left ventricular hypertrophy in normotensive African children populationGiuseppe Di Gioia, Antonio Creta, Cosimo Marco Campanale, et al.
Endocrine Connections|March 10, 2026
Neural plasticity impairment in chronic post-surgical hypoparathyroidism: a cross-sectional and prospective pilot studyAndrea Palermo, Gaia Tabacco, Anda Mihaela Naciu, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 22, 2024
Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation studyAlessandro Cruciani, Fioravante Capone, Shalom Haggiag, et al.
Pediatric Cardiology|August 26, 2019
Impact of Ethnicity on the Prevalence of Early Repolarization Pattern in Children: Comparison Between Caucasian and African PopulationsAntonio Creta, Michele Arigliani, Giuseppe di Gioia, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2025
Epilepsy in MS and its association with cognitive and psychological burdenValeria Pozzilli, Carla Tortorella, Luca Prosperini, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 3, 2021
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapiesFioravante Capone, Matteo Lucchini, Elisabetta Ferraro, et al.
Peerj|September 22, 2016
ECG is an inefficient screening-tool for left ventricular hypertrophy in normotensive African children populationGiuseppe Di Gioia, Antonio Creta, Cosimo Marco Campanale, et al.
Endocrine Connections|March 10, 2026
Neural plasticity impairment in chronic post-surgical hypoparathyroidism: a cross-sectional and prospective pilot studyAndrea Palermo, Gaia Tabacco, Anda Mihaela Naciu, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 22, 2024
Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation studyAlessandro Cruciani, Fioravante Capone, Shalom Haggiag, et al.
Pediatric Cardiology|August 26, 2019
Impact of Ethnicity on the Prevalence of Early Repolarization Pattern in Children: Comparison Between Caucasian and African PopulationsAntonio Creta, Michele Arigliani, Giuseppe di Gioia, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2025
Epilepsy in MS and its association with cognitive and psychological burdenValeria Pozzilli, Carla Tortorella, Luca Prosperini, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Pageof 4